We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 15 maart 2018

The Lancet: [Department of Error] Department of Error

[Department of Error] Department of Error
Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report. Lancet 2017; published online Oct 12. http://dx.doi.org/10.1016/S0140-6736(17)32513-8—In this Commission, Camilla Zimmermann's surname has been corrected, and Odontuya Davaasuren (Mongolian National University of Medical Science) has been included in the Acknowledgments section. Minor typographical and citation errors have also been corrected.
Read more

[Articles] 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
The increased risk of myocardial infarction with 6-month DAPT and the wide non-inferiority margin prevent us from concluding that short-term DAPT is safe in patients with acute coronary syndrome undergoing percutaneous coronary intervention with current-generation DES. Prolonged DAPT in patients with acute coronary syndrome without excessive risk of bleeding should remain the standard of care.
Read more

[Comment] 12 months of DAPT after acute coronary syndrome still beats 6 months
Why does the topic of optimal duration of dual antiplatelet therapy (DAPT) after an acute coronary syndrome treated by coronary stenting continue to generate such intense interest? We have sufficient evidence that acute coronary syndrome is caused by atherothrombosis. We also know that coronary stenting leads to further atherosclerotic plaque disruption, triggering thrombosis. Data from large registries have confirmed that the risk of recurrent myocardial infarction persists in the long term. Results of multiple trials have shown that DAPT reduces this risk.
Read more

[Correspondence] Open letter to The Global Fund about its decision to end DPRK grants
Dear Peter Sands and Aida Kurtović,
Read more

[Department of Error] Department of Error
Abu Taha A, Daoud A, Zaid S, Sammour S, Belleh M, Daifi R. Active surveillance for asymptomatic colonisation by multidrug-resistant bacteria in patients transferred to a tertiary care hospital in the occupied Palestinian territory. Lancet 2018; 391 (Research in the Occupied Palestinian Territory 2017 special issue): S2—In this Abstract, the source of funding has been corrected to An-Najah National University. This correction has been made to the online version as of March 14, 2018.
Read more